Saturday, June 13, 2020 1:03:21 PM
wow thats not a small number you invested in such a risky undertaken.
all water under the bridge now.
I have been introduced to NWBO in 2017 left in 2018 at break even and now like the gamble of what this will bring if the TLD curtain is lifted. If not when. Im in the green with NWBO.
May I ask you what is your average SP?
As you can see from my posts I have a very critical attitude towards NWBO management. My 2cents of what is going to happen in the next 3-4 months.
If NWBO comes up with more excuses not to reveal topline then its over, In that case you/we can all write off our investment and move on. In other words, I personally do not believe in the option for management to drag this on for longer than after September 2020.
Ok let's assume the science is solid and the(OS) TLD results are superb. Then, after TLD has been revealed,there still will be very high uncertainty if DCVAX will be approved given the new SAP and the, again lack of trancepary of the new SAP. I believe a company such as Merck if in place, will only be willing to invest in whatever form in DCVAX/NWBO, after approval for that exact same reason.
After TLD I expect to see an MC of 25% of total future revenue WW x4 so about 3 billion = between $ 1,5 and $ 3 per share in the weeks after TLD.
If I were you I would sell when at break-even and never look back.
all water under the bridge now.
I have been introduced to NWBO in 2017 left in 2018 at break even and now like the gamble of what this will bring if the TLD curtain is lifted. If not when. Im in the green with NWBO.
May I ask you what is your average SP?
As you can see from my posts I have a very critical attitude towards NWBO management. My 2cents of what is going to happen in the next 3-4 months.
If NWBO comes up with more excuses not to reveal topline then its over, In that case you/we can all write off our investment and move on. In other words, I personally do not believe in the option for management to drag this on for longer than after September 2020.
Ok let's assume the science is solid and the(OS) TLD results are superb. Then, after TLD has been revealed,there still will be very high uncertainty if DCVAX will be approved given the new SAP and the, again lack of trancepary of the new SAP. I believe a company such as Merck if in place, will only be willing to invest in whatever form in DCVAX/NWBO, after approval for that exact same reason.
After TLD I expect to see an MC of 25% of total future revenue WW x4 so about 3 billion = between $ 1,5 and $ 3 per share in the weeks after TLD.
If I were you I would sell when at break-even and never look back.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
